The development of plasma derivatives for clinical use. A symposium summary.
D001331:Automation; D001782:Blood Donors; D001798:Blood Proteins / Q000302:isolation & purification*; D011232:Chemical Precipitation; D002802:Cholinesterases / Q000302:isolation & purification; D002846:Chromatography, Affinity; D002850:Chromatography, Gel; D002852:Chromatography, Ion Exchange; D004335:Drug and Narcotic Control; D000431:Ethanol; D005169:Factor VIII; D005176:Factor XIII / Q000302:isolation & purification; D005249:Fees and Charges; D006509:Hepatitis B / Q000517:prevention & control; D006511:Hepatitis B Antigens / Q000302:isolation & purification; D006801:Humans; D007880:Legislation, Drug; D008722:Methods; D010949:Plasma / Q000032:analysis*; D010956:Plasmapheresis; D014481:United States
D001798:Blood Proteins; D006511:Hepatitis B Antigens; D000431:Ethanol; D005169:Factor VIII; D005176:Factor XIII; D002802:Cholinesterases